“…Even the basal level of extracellular adenosine, and the corresponding tonic activation of ARs, can be responsible of the modulatory activity on synaptic transmission (see Fredholm et al, 2005). Furthermore, AR activation is necessary, as co-receptor requirement, either to permit or to enhance neuronal and glial response to purines (ATP, Gerwins and Fredholm, 1992;Färber et al, 2008), neuropeptides (VIP, Cunha-Reis et al, 2007; CGRP, Sebastião et al, 2000;GDNF, Gomes et al, 2009), cytokines (IL-6, Biber et al, 2008, growth and trophic factors (FGF, Flajolet et al, 2008;BDNF, Diógenes et al, 2004), and chemokines (CX3CL1, Lauro et al, 2008). Data reported in this study show that adenosine, in addition to its wellknown direct neuroprotective effect on neurons (see above) and indirect protective effects through CCL2, IL-6, and S-100b release by astrocytes (Schwaninger et al, 1997;Ciccarelli et al, 1999;Wittendorp et al, 2004), appears to enable the neurotrophic activity of different neurotrophins to occur, thereby extending the repertoire of actions for adenosine in brain homeostatic control.…”